Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 6
2005 3
2006 4
2007 10
2008 11
2009 6
2010 4
2011 6
2012 15
2013 17
2014 10
2015 22
2016 17
2017 11
2018 12
2019 16
2020 22
2021 21
2022 30
2023 29
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Results by year

Filters applied: . Clear all
Page 1
Exploring the depths of IgG4: insights into autoimmunity and novel treatments.
Ünlü S, Sánchez Navarro BG, Cakan E, Berchtold D, Meleka Hanna R, Vural S, Vural A, Meisel A, Fichtner ML. Ünlü S, et al. Among authors: meisel a. Front Immunol. 2024 Apr 18;15:1346671. doi: 10.3389/fimmu.2024.1346671. eCollection 2024. Front Immunol. 2024. PMID: 38698867 Free PMC article. Review.
Functional Signature of LRP4 Antibodies in Myasthenia Gravis.
Chuquisana O, Stascheit F, Keller CW, Pučić-Baković M, Patenaude AM, Lauc G, Tzartos S, Wiendl H, Willcox N, Meisel A, Lünemann JD. Chuquisana O, et al. Among authors: meisel a. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200220. doi: 10.1212/NXI.0000000000200220. Epub 2024 Mar 20. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38507656 Free PMC article.
Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters - a pilot study.
Mehnert A, Bershan S, Kollmus-Heege J, Gerischer L, Herdick ML, Hoffmann S, Lehnerer S, Scheibe F, Stascheit F, Stein M, Buchan AM, Meisel A, Aigner A, Mergenthaler P. Mehnert A, et al. Among authors: meisel a. Front Neurol. 2024 Feb 26;15:1297997. doi: 10.3389/fneur.2024.1297997. eCollection 2024. Front Neurol. 2024. PMID: 38469587 Free PMC article.
POLAR: prediction of prolonged mechanical ventilation in patients with myasthenic crisis.
Heider D, Stetefeld H, Meisel A, Bösel J, Artho M, Linker R, Angstwurm K, Neumann B; German Myasthenic Crisis Study Group. Heider D, et al. Among authors: meisel a. J Neurol. 2024 May;271(5):2875-2879. doi: 10.1007/s00415-024-12208-4. Epub 2024 Feb 8. J Neurol. 2024. PMID: 38329540 Free PMC article. No abstract available.
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, De Bleecker JL, Murai H, Meisel A, Beydoun SR, Pasnoor M, Guglietta A, Van Hoorick B, Steeland S, T'joen C, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT+ Study Group. Howard JF Jr, et al. Among authors: meisel a. Front Neurol. 2024 Jan 17;14:1284444. doi: 10.3389/fneur.2023.1284444. eCollection 2023. Front Neurol. 2024. PMID: 38318236 Free PMC article.
244 results